Fibroids Flashcards
Fibroid makeup
Mixture of smooth muscle cells and fibroblasts, which form hard, round, worked tumors in the myometrium
Pathophysiology unknown
What controls the growth of fibroids?
Oestrogen and progesterone
Risk factors for fibroids
Race - black and Asian women Heredity Age Earlier menarche (before age 11) Nulliparity No use of contraception Obesity Dietary - alcohol
Treatment of fibroids (surgical)
Hysterectomy
Myometrium
Uterine artery embolisation
Myosure/hysteroscopy
Medical treatment of fibroids
Mefenatmic acid TXA Hormonal treatments Ulipristal acetate GNRH-A
Risk of leiomysarcoma
2.94:1000 or 1 in 340
Symptoms of fibroids
Menorrhagia Frequent urination Incomplete emptying of bladder Pelvic pressure Constipation Backache or leg pain Anaemia AUB Dyspaerunia
Uterine artery embolisation procedure
IR vascular catheter into common femoral artery to uterine arteries where embolic agent is injected until blood flow to uterine arteries appears sluggish
Role of preoperative GnRHa
3-4 month course
Reduces fibroid size and uterine volume - can potentially avoid midline
Improves preoperative haemoglobin levels
Reduces perioperative mood loss and transfusion requirements
Effect on fertility
Removal of intricacies component of submucous fibroid improves fertilit
Subserosal fibroids do not affect fertility outcome
Intramural fibroids appear to decrease fertility, particularly those that distort the uterine cavity
Ulipristal acetate
Selective. Progesterone receptor modulator that reversible blocs the progesterone receptor in the endometrium and myometrium
Net effect is inhibition of ovulation without significant effects on estradiol levels or glucocorticoid activity
Submucous fibroid classification
0 - no intramural extension
1 - <50% intramural extension
2- >50% intramural extension
Myosure/hysteroscopies myomectomy
HMB decreases by >80%
Increases fertility by 40-60%
Secondary treatment 2 year 10%, 5 year 30%
Complication rate 1-2%
Additional treatment: endometrial ablation +/- Mirena
Abdominal myometomy
80% improvement in AUB Uncertain if improves fertility over 41 Low conversion rate to hyst (<1%) Comparable surgical morbidity risk to hysterectomy Re-treatment rates: 20% over 2-5 years
UAE risks
Sloughing tumor into uterine or abdo cavity
Pelvic sepsis
Anaphylaxis to contrast
Bleeding from puncture site
Precipitate menopause (2-8%)
Unable to exclude leiomyosarcoma presence
**can’t do on pedunculated fibroids